KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 101 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 1.43 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $450,000 | -62.9% | 132,286 | -59.0% | 0.00% | – |
| Q2 2018 | $1,214,000 | +6.1% | 322,803 | +15.5% | 0.00% | – |
| Q1 2018 | $1,144,000 | -61.3% | 279,602 | -56.0% | 0.00% | -100.0% |
| Q4 2017 | $2,956,000 | +42.0% | 635,772 | +117.0% | 0.00% | 0.0% |
| Q3 2017 | $2,081,000 | +10.9% | 292,983 | +12.9% | 0.00% | 0.0% |
| Q2 2017 | $1,876,000 | +43.9% | 259,515 | +22.5% | 0.00% | +100.0% |
| Q1 2017 | $1,304,000 | +26.2% | 211,866 | +20.2% | 0.00% | 0.0% |
| Q4 2016 | $1,033,000 | +23.7% | 176,309 | +12.2% | 0.00% | 0.0% |
| Q3 2016 | $835,000 | -22.6% | 157,200 | -3.6% | 0.00% | 0.0% |
| Q2 2016 | $1,079,000 | +148.6% | 163,016 | +75.4% | 0.00% | 0.0% |
| Q1 2016 | $434,000 | – | 92,950 | +9294900.0% | 0.00% | – |
| Q4 2015 | $0 | -100.0% | 1 | -100.0% | 0.00% | – |
| Q3 2015 | $146,000 | -44.3% | 41,352 | +57.4% | 0.00% | – |
| Q2 2015 | $262,000 | -23.4% | 26,273 | -2.3% | 0.00% | – |
| Q1 2015 | $342,000 | -79.0% | 26,899 | -76.6% | 0.00% | -100.0% |
| Q4 2014 | $1,627,000 | -48.1% | 114,993 | -49.5% | 0.00% | -33.3% |
| Q3 2014 | $3,133,000 | +984.1% | 227,887 | +1111.4% | 0.00% | – |
| Q2 2014 | $289,000 | -91.8% | 18,812 | -90.9% | 0.00% | -100.0% |
| Q1 2014 | $3,510,000 | +60.6% | 205,961 | +22.1% | 0.00% | +33.3% |
| Q4 2013 | $2,186,000 | +416.8% | 168,737 | +303.3% | 0.00% | +200.0% |
| Q3 2013 | $423,000 | -10.4% | 41,837 | -33.7% | 0.00% | 0.0% |
| Q2 2013 | $472,000 | – | 63,121 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $3 | 0.00% |